IOL CHEMICALS & PHARM. | KOPRAN. | IOL CHEMICALS & PHARM./ KOPRAN. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 12.4 | 30.9 | 40.1% | View Chart |
P/BV | x | 1.4 | 2.8 | 49.6% | View Chart |
Dividend Yield | % | 1.1 | 1.2 | 95.3% |
IOL CHEMICALS & PHARM. KOPRAN. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
KOPRAN. Mar-23 |
IOL CHEMICALS & PHARM./ KOPRAN. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 327 | 164.0% | |
Low | Rs | 272 | 96 | 283.5% | |
Sales per share (Unadj.) | Rs | 377.6 | 114.3 | 330.4% | |
Earnings per share (Unadj.) | Rs | 23.7 | 5.6 | 419.5% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 8.3 | 380.9% | |
Dividends per share (Unadj.) | Rs | 4.00 | 3.00 | 133.3% | |
Avg Dividend yield | % | 1.0 | 1.4 | 69.8% | |
Book value per share (Unadj.) | Rs | 256.8 | 91.1 | 281.9% | |
Shares outstanding (eoy) | m | 58.71 | 48.21 | 121.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.9 | 57.8% | |
Avg P/E ratio | x | 17.1 | 37.5 | 45.5% | |
P/CF ratio (eoy) | x | 12.8 | 25.5 | 50.2% | |
Price / Book Value ratio | x | 1.6 | 2.3 | 67.8% | |
Dividend payout | % | 16.9 | 53.1 | 31.8% | |
Avg Mkt Cap | Rs m | 23,743 | 10,205 | 232.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 499 | 336.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 5,510 | 402.4% | |
Other income | Rs m | 256 | 31 | 835.6% | |
Total revenues | Rs m | 22,427 | 5,541 | 404.8% | |
Gross profit | Rs m | 2,257 | 518 | 435.7% | |
Depreciation | Rs m | 462 | 127 | 363.1% | |
Interest | Rs m | 165 | 61 | 270.8% | |
Profit before tax | Rs m | 1,887 | 361 | 523.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 88 | 560.5% | |
Profit after tax | Rs m | 1,391 | 272 | 510.9% | |
Gross profit margin | % | 10.2 | 9.4 | 108.3% | |
Effective tax rate | % | 26.2 | 24.5 | 107.2% | |
Net profit margin | % | 6.3 | 4.9 | 127.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 3,991 | 242.2% | |
Current liabilities | Rs m | 5,025 | 1,770 | 284.0% | |
Net working cap to sales | % | 20.9 | 40.3 | 51.9% | |
Current ratio | x | 1.9 | 2.3 | 85.3% | |
Inventory Days | Days | 43 | 11 | 406.7% | |
Debtors Days | Days | 8 | 1,077 | 0.8% | |
Net fixed assets | Rs m | 11,017 | 2,506 | 439.6% | |
Share capital | Rs m | 587 | 482 | 121.8% | |
"Free" reserves | Rs m | 14,490 | 3,910 | 370.6% | |
Net worth | Rs m | 15,077 | 4,392 | 343.3% | |
Long term debt | Rs m | 0 | 179 | 0.0% | |
Total assets | Rs m | 20,684 | 6,497 | 318.4% | |
Interest coverage | x | 12.5 | 6.9 | 179.7% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.8 | 126.4% | |
Return on assets | % | 7.5 | 5.1 | 146.7% | |
Return on equity | % | 9.2 | 6.2 | 148.8% | |
Return on capital | % | 13.6 | 9.2 | 147.6% | |
Exports to sales | % | 26.7 | 44.7 | 59.8% | |
Imports to sales | % | 0 | 10.1 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 2,464 | 240.6% | |
Imports (cif) | Rs m | NA | 558 | 0.0% | |
Fx inflow | Rs m | 5,930 | 2,464 | 240.6% | |
Fx outflow | Rs m | 6,052 | 624 | 969.2% | |
Net fx | Rs m | -122 | 1,840 | -6.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 340 | 359.4% | |
From Investments | Rs m | -1,200 | -127 | 948.6% | |
From Financial Activity | Rs m | -41 | -198 | 20.7% | |
Net Cashflow | Rs m | -18 | 15 | -120.4% |
Indian Promoters | % | 48.2 | 44.5 | 108.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 2.5 | 0.6 | 409.7% | |
FIIs | % | 2.2 | 0.5 | 454.2% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 55.5 | 93.4% | |
Shareholders | 134,235 | 51,636 | 260.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | KOPRAN. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.31% | 4.62% | 1.18% |
1-Month | -9.26% | 4.47% | -0.75% |
1-Year | 29.97% | 162.07% | 61.82% |
3-Year CAGR | -13.41% | 36.17% | 18.16% |
5-Year CAGR | 13.41% | 45.30% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the KOPRAN. share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of KOPRAN. the stake stands at 44.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of KOPRAN..
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
KOPRAN. paid Rs 3.0, and its dividend payout ratio stood at 53.1%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of KOPRAN..
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.